718.41
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$720.82
Aprire:
$723.08
Volume 24 ore:
528.84K
Relative Volume:
0.54
Capitalizzazione di mercato:
$88.11B
Reddito:
$359.05B
Utile/perdita netta:
$3.30B
Rapporto P/E:
27.81
EPS:
25.83
Flusso di cassa netto:
$5.23B
1 W Prestazione:
-1.34%
1M Prestazione:
+0.43%
6M Prestazione:
+24.18%
1 anno Prestazione:
+18.98%
Mckesson Corporation Stock (MCK) Company Profile
Nome
Mckesson Corporation
Settore
Industria
Telefono
972-446-4800
Indirizzo
6555 STATE HIGHWAY 161, IRVING, TX
Confronta MCK con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
MCK
Mckesson Corporation
|
718.41 | 88.11B | 359.05B | 3.30B | 5.23B | 25.83 |
![]()
COR
Cencora Inc
|
292.32 | 55.56B | 310.23B | 1.69B | 3.58B | 8.62 |
![]()
CAH
Cardinal Health Inc
|
163.75 | 36.54B | 222.29B | 1.56B | 2.44B | 6.41 |
![]()
HSIC
Henry Schein Inc
|
72.79 | 8.92B | 12.50B | 314.00M | 421.00M | 2.44 |
![]()
OMI
Owens Minor Inc
|
7.86 | 623.64M | 10.42B | -38.77M | 323.54M | -0.51 |
Mckesson Corporation Stock (MCK) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-04 | Ripresa | Mizuho | Neutral |
2024-11-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2024-09-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
2024-09-05 | Reiterato | Leerink Partners | Outperform |
2024-08-08 | Reiterato | Mizuho | Neutral |
2024-02-26 | Iniziato | Leerink Partners | Outperform |
2024-01-03 | Iniziato | Barclays | Overweight |
2023-12-14 | Iniziato | Wells Fargo | Equal Weight |
2023-03-31 | Iniziato | Citigroup | Buy |
2022-08-22 | Ripresa | Morgan Stanley | Overweight |
2022-07-06 | Downgrade | Argus | Buy → Hold |
2022-06-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
2022-04-01 | Ripresa | Credit Suisse | Outperform |
2022-02-04 | Downgrade | Deutsche Bank | Buy → Hold |
2022-01-07 | Aggiornamento | Credit Suisse | Neutral → Outperform |
2021-11-02 | Reiterato | Barclays | Overweight |
2021-11-02 | Reiterato | BofA Securities | Buy |
2021-11-02 | Reiterato | Evercore ISI | Outperform |
2021-11-02 | Reiterato | Jefferies | Buy |
2021-03-30 | Aggiornamento | Argus | Hold → Buy |
2020-11-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
2020-08-04 | Aggiornamento | Deutsche Bank | Hold → Buy |
2020-05-22 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
2020-05-15 | Aggiornamento | UBS | Neutral → Buy |
2020-04-23 | Ripresa | Credit Suisse | Neutral |
2020-03-18 | Aggiornamento | Goldman | Neutral → Buy |
2020-03-13 | Aggiornamento | Guggenheim | Neutral → Buy |
2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2020-01-10 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2019-09-12 | Iniziato | Deutsche Bank | Hold |
2019-08-05 | Downgrade | Wolfe Research | Outperform → Peer Perform |
2019-07-22 | Iniziato | Guggenheim | Neutral |
2019-01-17 | Iniziato | UBS | Neutral |
2018-10-26 | Reiterato | Barclays | Equal Weight |
2018-07-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
2018-05-29 | Reiterato | Leerink Partners | Mkt Perform |
2018-03-08 | Iniziato | Barclays | Equal Weight |
2018-02-27 | Ripresa | BofA/Merrill | Buy |
2018-02-02 | Reiterato | Mizuho | Neutral |
2018-01-24 | Aggiornamento | Jefferies | Hold → Buy |
Mostra tutto
Mckesson Corporation Borsa (MCK) Ultime notizie
McKesson Corporation (MCK) Surged Following a Decent Set of Results - Insider Monkey
Here's Why McKesson (MCK) is a Strong Value Stock - Yahoo Finance
Healthcare's Digital Dilemma Market to See Drastic GrowthPost - openPR.com
Why McKesson (MCK) is a Top Growth Stock for the Long-Term - Yahoo Finance
Morgan Stanley Hikes McKesson (MCK) Price Target on Earnings Growth Prospects - Insider Monkey
Wells Fargo Affirms McKesson (MCK) Equal Weight Rating and $766 Price Target - Insider Monkey
Leerink Partners Remains Bullish on McKesson Corporation (MCK), Retains a $785 Price Target - Insider Monkey
Here's How Much $100 Invested In McKesson 20 Years Ago Would Be Worth Today - Benzinga
McKesson (MCK) Rises Higher Than Market: Key Facts - Yahoo Finance
Stan Wong's Top Picks: iShares Silver Bullion ETF, McKesson & Nvidia - BNN Bloomberg
McKesson (NYSE:MCK) Price Target Raised to $770.00 at Morgan Stanley - Defense World
McKesson Adjusts Earnings Outlook Amid Pharma Growth - Finimize
McKesson Boosts Fiscal 2026 EPS Guidance on Operational Strength, Morgan Stanley Says - marketscreener.com
McKesson (MCK) Price Target Raised by Morgan Stanley | MCK Stock News - GuruFocus
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know - Yahoo Finance
McKesson to Host Investor Day on September 23, 2025 - BioSpace
McKesson to Host Investor Day on September 23, 2025 | MCK Stock News - GuruFocus
McKesson (MCK) Revises Earnings Projections for Fiscal Year 2026 - GuruFocus
McKesson (MCK) Price Target Raised by Morgan Stanley to $770 | M - GuruFocus
McKesson price target raised to $770 from $745 at Morgan Stanley - TipRanks
McKesson (MCK) Revises Earnings Projections for Fiscal Year 2026 | MCK Stock News - GuruFocus
McKesson (MCK) Price Target Raised by Morgan Stanley to $770 | MCK Stock News - GuruFocus
Those who invested in McKesson (NYSE:MCK) five years ago are up 366% - simplywall.st
McKesson stock price target raised at Morgan Stanley on growth outlook - Investing.com India
Global Clinical Workflow Management Software Market Projected to Reach USD USD 40,243 million by 2030., Growing at a 22.97% CAGR: MarkNtel AdvisorsLeading key players (GE Healthcare, Oracle Health, Allscripts Healthcare Solutions, Siemens Heal - The Malaysian Reserve
McKesson Corporation (MCK) Updates Fiscal Year 2026 Financial Outlook - GuruFocus
McKesson CEO Tyler Brian S. sells shares for $13.67 million By Investing.com - Investing.com South Africa
McKesson CEO Tyler Brian S. sells shares for $13.67 million - Investing.com
McKesson Stock: Is Wall Street Bullish or Bearish? - MSN
Mckesson Says Executives To Meet With Investors And AnalystsSEC Filing - MarketScreener
McKesson Updates Fiscal Year 2026 Financial Outlook - TipRanks
McKesson Raises FY Earnings Outlook - MarketWatch
McKesson leads the charge in revolutionizing precision oncology in community practices - Endpoints News
McKesson Stock: Is MCK Outperforming the Healthcare Sector? - MSN
McKesson Corporation Acquires Florida Cancer Specialists Core Ventures to Expand Community-Based Oncology Care - geneonline.com
Wells Fargo Raises McKesson (MCK) Price Target, Maintains Equal Weight Rating - MSN
Mizuho Adjusts Price Target on McKesson to $735 From $690, Maintains Neutral Rating - marketscreener.com
3 Reasons We Love McKesson (MCK) - FinancialContent
McKesson Corporation Acquires Florida Cancer Specialists to Expand Community-Based Oncology Care - geneonline.com
McKesson Stock: Is MCK Outperforming The Healthcare Sector? - Barchart.com
McKesson completes acquisition of Core Ventures - Drug Store News
Wells Fargo & Company Issues Positive Forecast for McKesson (NYSE:MCK) Stock Price - Defense World
McKesson acquires majority stake in Core Ventures By Investing.com - Investing.com South Africa
McKesson Corporation (MCK) Finalizes Purchase of Core Ventures - Insider Monkey
McKesson (MCK): Wells Fargo Raises Price Target to $766 | MCK St - GuruFocus
McKesson Acquires 70% Stake In Core Ventures To Boost Community Oncology Access - Nasdaq
McKesson completes control acquisition of cancer care clinics for $2.5B - The Business Journals
McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
Mckesson Corporation Azioni (MCK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):